Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen.

Targeting HER2-positive cancer cells with receptor-redirected anthrax protective antigen. Mol Oncol. 2013 Jun; 7(3):440-51.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.